CL2004000045A1 - HETEROAROMATIC COMPOUNDS DERIVED FROM PIPERAZINA, PHARMACEUTICAL COMPOSITION, USEFUL TO TREAT AN ILLNESS LIKE CANCER. - Google Patents
HETEROAROMATIC COMPOUNDS DERIVED FROM PIPERAZINA, PHARMACEUTICAL COMPOSITION, USEFUL TO TREAT AN ILLNESS LIKE CANCER.Info
- Publication number
- CL2004000045A1 CL2004000045A1 CL200400045A CL2004000045A CL2004000045A1 CL 2004000045 A1 CL2004000045 A1 CL 2004000045A1 CL 200400045 A CL200400045 A CL 200400045A CL 2004000045 A CL2004000045 A CL 2004000045A CL 2004000045 A1 CL2004000045 A1 CL 2004000045A1
- Authority
- CL
- Chile
- Prior art keywords
- piperazina
- illness
- cancer
- treat
- useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
N-ARIL-HETEROAROMATICOS DE FORMULAS, COMPOSICIONES QUE LOS CONTIENEN Y SU USO COMO MEDICAMENTOS, EN PARTICULAR ONCOLOGIA.N-ARIL-HETEROAROMATICOS OF FORMULAS, COMPOSITIONS THAT CONTAIN THEM AND ITS USE AS MEDICATIONS, IN PARTICULAR ONCOLOGY.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0300894A FR2850379B1 (en) | 2003-01-28 | 2003-01-28 | N-ARYL-HETEROAROMATIC PRODUCTS, COMPOSITIONS CONTAINING SAME AND USE THEREOF |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2004000045A1 true CL2004000045A1 (en) | 2005-01-07 |
Family
ID=32669255
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL200400045A CL2004000045A1 (en) | 2003-01-28 | 2004-01-13 | HETEROAROMATIC COMPOUNDS DERIVED FROM PIPERAZINA, PHARMACEUTICAL COMPOSITION, USEFUL TO TREAT AN ILLNESS LIKE CANCER. |
Country Status (9)
Country | Link |
---|---|
AR (1) | AR042900A1 (en) |
CL (1) | CL2004000045A1 (en) |
FR (1) | FR2850379B1 (en) |
GT (1) | GT200300267A (en) |
PA (1) | PA8594301A1 (en) |
PE (1) | PE20040766A1 (en) |
SV (1) | SV2004001710A (en) |
TW (1) | TW200504026A (en) |
UY (1) | UY28173A1 (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3449350A (en) * | 1968-06-24 | 1969-06-10 | Ciba Geigy Corp | Certain pyrazole-3-carboxylic acid hydrazide derivatives |
US3778433A (en) * | 1969-04-18 | 1973-12-11 | Sumitomo Chemical Co | Process for producing benzodiazepine derivatives |
JPS61129129A (en) * | 1984-11-28 | 1986-06-17 | Kureha Chem Ind Co Ltd | Antitumor agent |
TW312694B (en) * | 1994-09-26 | 1997-08-11 | Daiichi Seiyaku Co | |
EA005934B1 (en) * | 2001-07-05 | 2005-08-25 | Х. Лундбекк А/С | Substituted anilinic piperidines as mch selective antagonists |
-
2003
- 2003-01-28 FR FR0300894A patent/FR2850379B1/en not_active Expired - Fee Related
- 2003-12-03 GT GT200300267A patent/GT200300267A/en unknown
- 2003-12-04 PE PE2003001229A patent/PE20040766A1/en not_active Application Discontinuation
-
2004
- 2004-01-13 CL CL200400045A patent/CL2004000045A1/en unknown
- 2004-01-19 AR ARP040100138A patent/AR042900A1/en unknown
- 2004-01-22 PA PA20048594301A patent/PA8594301A1/en unknown
- 2004-01-27 SV SV2004001710A patent/SV2004001710A/en unknown
- 2004-01-27 TW TW093101686A patent/TW200504026A/en unknown
- 2004-01-28 UY UY28173A patent/UY28173A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR042900A1 (en) | 2005-07-06 |
UY28173A1 (en) | 2004-08-31 |
PE20040766A1 (en) | 2004-12-14 |
PA8594301A1 (en) | 2004-08-31 |
FR2850379A1 (en) | 2004-07-30 |
GT200300267A (en) | 2004-02-24 |
TW200504026A (en) | 2005-02-01 |
FR2850379B1 (en) | 2006-11-17 |
SV2004001710A (en) | 2004-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2012002844A1 (en) | Compounds derived from chromen-2-one; pharmaceutical composition that includes them; and its use in the treatment of a proliferative cell disorder such as cancer (divisional application No. 311-07). | |
ECSP078013A (en) | MEK HETEROCYCLIC INHIBITORS AND METHODS OF USE OF THEM | |
CL2008001633A1 (en) | Compounds derived from pyrrolidin-3-carboxamide; pharmaceutical composition; and use as erk inhibitors for the treatment of cancer. | |
GT200900027A (en) | ORGANIC COMPOUNDS | |
CL2008002319A1 (en) | Compounds derived from pyrrolopyrimidine; pharmaceutical composition comprising said compounds; and its use to treat cancer. | |
CL2007001995A1 (en) | Compounds derived from pyrrolotriazine; pharmaceutical composition comprising said compounds; and its use to treat cancer. | |
CR20140544A (en) | COMPOUNDS TO INHIBIT THE MYTHICAL PROGRESSION | |
CL2011001215A1 (en) | Compounds derived from pyrimidine, tyrosine kinase inhibitors; pharmaceutical compositions comprising them; and its use in the treatment and / or prevention of cancer, inflammatory diseases and autoimmune diseases. | |
CL2011000691A1 (en) | Compounds derived from substituted nicotinamide; pharmaceutical composition that includes them; use for the treatment and / or prevention of cancer, infections, inflammatory and autoimmune diseases. | |
CL2008003265A1 (en) | Compounds derived from nitrogenous heterocycles, suppressors of collagen production; pharmaceutical composition comprising said compounds; and its use to prevent and / or treat fibrosis and / or tumors. | |
CL2011000527A1 (en) | Compounds derived from benzofuran; pharmaceutical composition that includes them; and their use in the treatment of hepatitis c. | |
CL2011003082A1 (en) | Compounds derived from [1,2,4] triazolo [1,5-a] pyridine, jak2 or fak inhibitors; pharmaceutical compositions comprising them; and its use for the treatment of a hyperproliferative disease. | |
CL2007003212A1 (en) | COMPOUNDS DERIVED FROM IMIDAZOPIRAZINS, INHIBITORS OF PROTEIN QUINASA; PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS THEM; AND ITS USE TO TREAT CANCER. | |
CL2007003226A1 (en) | COMPOUNDS DERIVED FROM PIRIDINONA; PHARMACEUTICAL COMPOSITION; AND USE TO TREAT CANCER. | |
GT200600520A (en) | ANTIBACTERIAL AGENTS | |
UY31673A1 (en) | "UREA HETEROCYCLIC DERIVATIVES AND METHODS OF USE OF THE SAME-211" | |
CL2012002189A1 (en) | Compounds derived from substituted pyrrolidine-2-carboxamides; mdm2-p53 interaction inhibitors; pharmaceutical composition; and its use for the treatment of cancer, particularly solid tumors. | |
CL2007001996A1 (en) | Compounds derived from phenyl substituted nitrogen heteroaryls, inhibitors of cytokine production; pharmaceutical composition that includes them; and its uses in the treatment of cancer, infections, inflammatory and autoimmune diseases. | |
UY30759A1 (en) | CHEMICAL COMPOUNDS | |
BRPI0807146B8 (en) | akt activity inhibitor compounds, their use in the treatment of cancer and arthritis, as well as a pharmaceutical composition comprising them | |
UY30748A1 (en) | NEW COMPOUNDS | |
SV2010003559A (en) | SOME DERIVATIVES OF 2-PIRAZINONA AND ITS USE AS INHIBITORS OF ELASTASA DE LOS NEUTROFILOS | |
CL2008002295A1 (en) | Alkylsulfonyl-substituted thiazolid derivative compounds; pharmaceutical composition; and use for the treatment of hepatitis c. | |
UY29767A1 (en) | BENZOTIAZOLONAS DERIVATIVES, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS | |
CL2008002893A1 (en) | Substituted n-phenyl- (pyridin-3-yl) acetamide derivative compounds; pharmaceutical composition; preparation procedure; and its use to prevent or treat cancer. |